Skip to main content
. 2021 Mar 23;34:100793. doi: 10.1016/j.eclinm.2021.100793

Table 1.

General characteristics of study population (patients who “cleared” after previously being SARS-CoV-2 positive) for hospitalized and non-hospitalized post-clearance cohorts. Demographic variables and comorbidities in the hospitalized and non-hospitalized post-clearance cohorts. Frequency and proportions (n (%)) are shown for the categorical variables, and mean, median, standard deviation, and interquartile range (IQR) are shown for the continuous variables. The columns are: (1) Hospitalized post-clearance: clinical characteristics of the cohort of patients who are admitted or readmitted to the hospital following the estimated clearance date of SARS-CoV-2 infection, (2) Non-Hospitalized post-clearance: clinical characteristics of the control group of patients who are not admitted to the hospital following the estimated clearance date, (3) BH-corrected p-value: Benjamani-Hochberg corrected p-values using Fisher's exact test for comparisons of proportions and Mann-Whitney U test for continuous covariates.

Clinical covariate Hospitalized Post-Clearance Non-Hospitalized Post-Clearance BH-adjusted p-value
Total number of patients 49 173
Age in years
  • -

    Mean

  • -

    Median

  • -

    Standard deviation

  • -

    IQR
58.9
61.8
18.5
(47.6, 72.5)
58.5
58.9
16.7
(49.4, 71.6)
0.959
Relative Cleared Date in days (standard deviation)
  • -

    Mean

  • -

    Median

  • -

    Standard deviation

  • -

    IQR
21.7
20.0
13.5
(14.0, 31.0)
21.7
20.0
12.8
(14.0, 29.0)		 0.993
Sex
  • -

    Female

  • -

    Male
25 (51.0%)
24 (49.0%)
71 (41.0%)
102 (59.0%)
0.697
0.697
Race
  • -

    White

  • -

    Asian

  • -

    Black

  • -

    Other
32 (65.3%)
1 (2.0%)
4 (8.2%)
12 (24.5%)
104 (60.1%)
18 (10.4%)
22 (12.7%)
29 (16.8%)
0.849
0.697
0.843
0.697
Ethnicity
  • -

    Hispanic

  • -

    Non-Hispanic

  • -

    Other
9 (18.4%)
39 (79.6%)
1 (2.0%)
39 (22.5%)
127 (73.4%)
7 (4.0%)
0.849
0.843
0.849
Comorbidities
  • -

    Asthma

  • -

    Cancer

  • -

    Chronic kidney disease

  • -

    Chronic obstructive pulmonary disease

  • -

    Obesity

  • -

    Obstructive sleep apnea

  • -

    Type 1 diabetes mellitus

  • -

    Type 2 diabetes mellitus
5 (10.2%)
8 (16.3%)
9 (18.4%)
4 (8.2%)
7 (14.3%)
6 (12.2%)
1 (2.0%)
11 (22.4%)
9 (5.2%)
21 (12.1%)
15 (8.7%)
5 (2.9%)
16 (9.2%)
15 (8.7%)
2 (1.2%)
31 (17.9%)
0.476
0.536
0.271
0.333
0.536
0.536
0.536
0.536